Elizabeth Faust
Director/Board Member at BIOMEA FUSION, INC.
Net worth: - $ as of 2024-03-30
Profile
Elizabeth A.
Faust is currently an Independent Director at Biomea Fusion, Inc. since 2022 and the Principal & Owner of Faust Consulting LLC since 2018.
Previously, she held positions such as Executive Director-Regional Medical Liaisons at Amgen, Inc., Senior Director-Medical Affairs at Gloucester Pharmaceuticals, Inc. from 2008 to 2010, Vice President-Medical Affairs at Pharmacyclics LLC from 2013 to 2015, Executive Vice President-Medical Affairs at Tricida, Inc. from 2019 to 2020, Vice President-Clinical Research Sciences at Celgene Corp., Vice President-Medical Affairs at Kite Pharma, Inc. from 2016 to 2018, and Vice President-Medical Affairs at Pharmacyclics, Inc. from 2013 to 2015.
Dr. Faust holds a doctorate degree from the University of California, Los Angeles, an undergraduate degree from Auburn University, and a graduate degree from the University of California, Riverside.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOMEA FUSION INC
-.--% | 2023-06-13 | 0 ( -.--% ) | - $ | 2024-03-30 |
Elizabeth Faust active positions
| Companies | Position | Start |
|---|---|---|
| BIOMEA FUSION, INC. | Director/Board Member | 2022-05-31 |
Former positions of Elizabeth Faust
| Companies | Position | End |
|---|---|---|
| TRICIDA, INC. | Chief Tech/Sci/R&D Officer | 2020-07-31 |
| CELGENE | Chief Tech/Sci/R&D Officer | 2019-10-31 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | 2018-06-30 |
| PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | 2015-10-31 |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Chief Tech/Sci/R&D Officer | 2015-10-31 |
Training of Elizabeth Faust
| University of California, Los Angeles | Doctorate Degree |
| Auburn University | Undergraduate Degree |
| University of California, Riverside | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| TRICIDA, INC. | Health Technology |
| BIOMEA FUSION, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Health Technology |
- Stock Market
- Insiders
- Elizabeth Faust
